Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

Cancer cell stemness inhibitor BBI-608 safe and active in ongoing phase I trial

April 28, 2010

Greater HbA1c reductions with LY-2189265 in Hispanic patients with type 2 diabetes

April 28, 2010

Serum markers may identify children who will develop active multiple sclerosis

April 28, 2010

HCV NS5B polymerase inhibitor ABT-072 shows promising safety and pharmacokinetics

April 28, 2010

Final data disclosed from PROTECT trial of PEG-IFN-alfa2b/ribavirin

April 28, 2010

Temozolomide shows activity in pituitary tumors and carcinomas

April 27, 2010

Dual TLR7 and TLR9 antagonist has therapeutic effects in mouse model of atherosclerosis

April 27, 2010

EMD-1214063 displays potent and selective c-Met inhibition

April 27, 2010

Updated phase I data disclosed on IMO-2125 in HCV infection

April 27, 2010

INT-747 promising as add-on therapy to ursodeoxycholic acid for primary biliary cirrhosis

April 27, 2010

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 8, 2026.
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
Hematopoietic stem cell research points to leukemia’s early roots
BioWorld Science
Hematopoietic stem cell (HSC) research over the past century has shown that leukemia may be driven by an invisible hand of inflammation. The bone marrow and...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
Infinimmune presents preclinical data on anti-IL-22 antibody for atopic dermatitis
BioWorld Science
Infinimmune Inc. has recently presented results at the annual American Academy of Dermatology conference regarding their anti-IL-22 antibody IFX-101 for the...